Report Highlights

U.S. Role in the Global Manuka Honey Supply Chain

The United States operates as a high-value consumption and distribution hub rather than a producer of manuka honey. The Leptospermum scoparium shrub is native to New Zealand, where commercial hives in the Coromandel, Northland and Bay of Plenty regions supply the overwhelming majority of global volume. American buyers source almost all of their manuka through New Zealand exporters, making the US one of the largest value destinations for the New Zealand manuka trade alongside China and Germany.

Value-add happens largely inside the US, where importers repack, brand and certify product before distribution through Costco, Whole Foods, Amazon and pharmacy chains. Florida-based Wedderspoon manufactures manuka-infused products domestically, while Comvita USA handles brand distribution for the parent exporter. The main vulnerability is single-origin dependence combined with ocean freight through Auckland to West Coast ports, where congestion can delay shelf replenishment.

Growth Drivers for U.S. Manuka Honey Trade and Production

Demand for functional food and wound-care products is the primary engine pulling additional volume into US ports. Retailers have expanded manuka shelf space beyond health stores into mass grocery, while Amazon sellers import pallets of MGO-rated jars directly from Auckland. Manuka-infused cosmetics and oral-care formulations from US personal care brands are creating a second industrial channel for bulk honey.

Import substitution is limited because US beekeepers cannot produce authentic manuka, so growth depends on supply chain efficiency. Temperature-controlled warehousing in New Jersey, California and Texas protects high-grade honey during storage and regional distribution. Tighter testing protocols, including methylglyoxal verification at accredited US laboratories, are pushing importers toward certified batches, lifting unit values and shifting trade toward premium grades.

Supply Chain Risks and Trade Barriers

Raw material dependency is the dominant risk. New Zealand's manuka harvest is weather-dependent, and a single poor flowering season can cut volumes sharply. Because the US sources almost exclusively from one country, a drop in New Zealand output transmits directly into US wholesale pricing, with no alternative origin capable of supplying certified MGO grades at scale.

Trade barrier exposure has increased. US reciprocal tariff policy introduced in 2025 applied across-the-board duties to imports, raising landed cost for New Zealand exporters and importers alike. Adulteration also threatens the category, as mislabeled blends have drawn FDA and FTC scrutiny of health claims, and shipments lacking origin or testing documentation risk detention at port. Currency movement between the New Zealand dollar and US dollar compresses importer margins on fixed-price retail contracts.

Trade and Investment Opportunities in U.S. Manuka Honey

Bonded warehousing and value-added repacking near the Port of Los Angeles and Long Beach offer a clear logistics opportunity. Importers can convert bulk drums into US-finished retail packs, reducing inventory holding costs and enabling rapid response to replenishment orders. New Zealand processors can also establish US co-packing facilities in Texas or Florida, where proximity to beverage and nutraceutical manufacturers lowers distribution cost.

Export-side opportunity exists for US-branded manuka-infused products entering Canada and Japan, where American manufacturers can use established FDA-compliant facilities. Inbound investment is most attractive in traceability technology, including DNA marker testing laboratories and provenance platforms that satisfy retailer audit requirements. These platforms address the largest friction in the category: verifying that a jar labeled MGO 500+ actually contains the stated compound concentration.

Market at a Glance

Leading Market Participants

• Comvita
• Manuka Health
• Wedderspoon
• Egmont Honey
• Capilano Honey
• Manuka Doctor
• Arataki Honey
• Watson and Son
• Nature Nate's
• Comvita USA

Regulatory and Trade Policy Environment

Manuka honey enters the US under HTS 0409.00, which carries a normal trade relations rate of zero. However, New Zealand goods also face the baseline reciprocal tariff introduced in 2025, which applies on top of standard entry requirements. Importers must register food facilities with the FDA, file prior notice, and comply with FSMA preventive controls, while customs entries must carry accurate country-of-origin marking under 19 CFR Part 134.

Antidumping duties on Chinese honey, in force since 2001, reshape the broader honey market by steering buyers toward other origins, which indirectly benefits New Zealand exporters. Labeling is governed by FDA rules and FTC Section 5 on advertising claims, so UMF and MGO claims require substantiation. The FDA does not set a federal manuka grade standard, leaving private certification bodies to fill the gap.

U.S. Manuka Honey Supply Chain Outlook to 2032

The US position will remain import-dependent through 2032, with New Zealand producers consolidating into fewer, larger processors that maintain traceable hive registries. Shifts in North Island production will determine whether American importers face pricing stability. Trade flows are expected to move toward direct-to-retailer shipments through West Coast and Gulf ports, reducing reliance on distributor intermediaries.

Technology will alter comparative advantage. Rapid DNA-based authentication and portable spectroscopy testing will shift verification upstream to New Zealand processors, rewarding those with certified laboratory results. Importers without verifiable batch data will lose shelf access, consolidating the US market around a small group of certified brands by 2032.